NCT02693392 - Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

January 17, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

August 16, 2018

Conditions

Type-2 Diabetes Mellitus

Interventions

DRUG

Oral hypoglycemic agents (pre-specified) [Metformin, Sulfonylurea]

"Patients receiving either of the following oral hypoglycemic agents~1. Sulfonylurea based oral hypoglycemic agents~2. Metformin based oral hypoglycemic agents~3. Metformin plus Sulfonylurea based oral hypoglycemic agents"

DIETARY_SUPPLEMENT

Fenugreek Seed extract

Patients recruited in the study arm will receive Capsule Fenfuro 500 milligram twice daily for 12 weeks as add-on intervention to the pre-specified oral hypoglycemic agents therapy

Trial Locations (1)

751019

Department of Medicine and Department of Pharmacology, AIIMS, Bhubaneswar